Dr. Sung is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Elm and Carlton St
CGP L4-318
Buffalo, NY 14263Phone+1 716-845-7739
Education & Training
- University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2014 - 2018
- University of Pennsylvania Health SystemResidency, Internal Medicine, 2012 - 2014
- New York University School of MedicineClass of 2012
- Cornell UniversityBA, Biology, Chemistry, Cum Laude with Distinction in All Subjects, 2000 - 2004
Certifications & Licensure
- NY State Medical License 2021 - 2026
- PA State Medical License 2012 - 2022
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- PIKing the right target in AML.Pamela J Sung
Blood. 2024-05-09 - 6 citationsFLT3 tyrosine kinase inhibition modulates PRC2 and promotes differentiation in acute myeloid leukemia.Pamela J Sung, Murugan Selvam, Simone S Riedel, Hongbo M Xie, Katie Bryant
Leukemia. 2024-02-01 - 4 citationsGemtuzumab ozogamicin plus standard induction hemotherapy improves outcomes of newly diagnosed intermediate cytogenetic risk acute myeloid leukemia.Hassan Awada, Mina Abdelmalek, Tara Cronin, Jeffrey Baron, Zakariya Kashour
Blood Cancer Journal. 2023-09-04
Press Mentions
- Roswell Park Teams Draw More Than $36 Million in Research GrantJanuary 27th, 2022
- Roswell Park Hematologists Present New Research on FLT3 Inhibitors, CART-19 at ASH Annual MeetingDecember 11th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: